Avalo Therapeutics Inc (AVTX) — Financial Flexibility Index
Avalo Therapeutics Inc (AVTX) has a Financial Flexibility Index of -0.49x as of September 2025. Free cash flow of $-16.36 Million (operating CF $-16.36 Million minus capex $0.00) represents 0% of total liabilities ($33.55 Million). Check Avalo Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Avalo Therapeutics Inc Financial Flexibility Index (2012–2024)
Historical Financial Flexibility Index trend for Avalo Therapeutics Inc across 13 annual periods. For the full cash flow conversion analysis, see Avalo Therapeutics Inc cash conversion from operations.
Annual Financial Flexibility Index for Avalo Therapeutics Inc (2012–2024)
Year-by-year free cash flow to debt coverage for Avalo Therapeutics Inc. Explore Avalo Therapeutics Inc (AVTX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.77x | $-49.06 Million | $-49.06 Million | $17.70 Million | ▼ -24.3% |
| 2023 | -2.23x | $-30.52 Million | $-30.68 Million | $13.69 Million | ▼ -270.4% |
| 2022 | -0.60x | $-26.66 Million | $-26.75 Million | $44.28 Million | ▲ +51.4% |
| 2021 | -1.24x | $-70.78 Million | $-70.89 Million | $57.13 Million | ▲ +41.3% |
| 2020 | -2.11x | $-40.48 Million | $-40.54 Million | $19.19 Million | ▼ -68.9% |
| 2019 | -1.25x | $-18.87 Million | $-19.13 Million | $15.11 Million | ▼ -2303.4% |
| 2018 | -0.05x | $-2.56 Million | $-3.13 Million | $49.34 Million | ▼ -106.3% |
| 2017 | 0.82x | $12.54 Million | $12.52 Million | $15.26 Million | ▲ +131.4% |
| 2016 | -2.61x | $-14.54 Million | $-14.57 Million | $5.56 Million | ▼ -120.9% |
| 2015 | -1.18x | $-10.14 Million | $-10.16 Million | $8.57 Million | ▼ -195.0% |
| 2014 | -0.40x | $-15.50 Million | $-15.52 Million | $38.65 Million | ▲ +19.8% |
| 2013 | -0.50x | $-11.46 Million | $-11.49 Million | $22.92 Million | ▲ +91.7% |
| 2012 | -6.01x | $-9.28 Million | $-9.29 Million | $1.54 Million | — |